Literature DB >> 28566954

Demonstration of Early Cognitive Impairment in Parkinson's Disease with Visual P300 Responses.

Gülin Özmüş1, Deniz Yerlikaya1, Arife Gökçeoğlu1, Derya Durusu Emek Savaş2, Raif Çakmur3, Beril Dönmez Çolakoğlu3, Görsev G Yener3.   

Abstract

INTRODUCTION: Parkinson's disease (PD) is the second most common neurodegenerative disease after Alzheimer's disease. Cognitive changes in PD are less observable than motor symptoms; thus, research on cognitive processes, which are known to be impaired from the early stages of PD, is minimal. The purpose of this study is to research the brain dynamics of cognitively normal PD patients and healthy elderly controls using event-related potentials (ERPs) and to evaluate their relationships with neuropsychological tests.
METHODS: Eighteen cognitively normal PD patients and 18 age-, gender-, and education-matched healthy controls were included in the study. Detailed neuropsychological tests were applied to all participants. Electroencephalography (EEG) was performed according to the international 10-20 system, and a classical visual oddball paradigm was used in the experiments. ERP responses in the 0.5 to 25 Hz frequency range were examined. P300 amplitude and latency values were measured from the F3, Fz, F4, C3, Cz, C4, P3, Pz, P4, O1, Oz, and O2 electrode sites. In addition, the correlations between P300 responses and neuropsychological test scores were analyzed.
RESULTS: Significant differences were found between the P300 amplitudes of cognitively normal PD patients and healthy elderly controls [F(1,31)=9.265; p=0.005]. P300 amplitudes were significantly lower for PD patients at the F3, FZ, Cz, C4, Pz, and P4 electrode sites than for healthy elderly controls. Moderate correlations were found between Stroop test score and P4 amplitude, digit span forward and C3 and Pz amplitude, and digit span backward and O1 amplitude.
CONCLUSION: The major finding of this study was the detection of cognitive changes by electrophysiological methods in PD patients who were indicated to be cognitively normal by neuropsychological tests. These finding suggests that cognitive changes in PD patients, which are not yet reflected in neuropsychological tests, may be detected by electrophysiological methods in earlier stages.

Entities:  

Keywords:  P300; Parkinson’s disease; event-related potentials; visual

Year:  2017        PMID: 28566954      PMCID: PMC5439466          DOI: 10.5152/npa.2016.12455

Source DB:  PubMed          Journal:  Noro Psikiyatr Ars        ISSN: 1300-0667            Impact factor:   1.339


  53 in total

1.  Effect of interstimulus interval on visual P300 in Parkinson's disease.

Authors:  L Wang; Y Kuroiwa; T Kamitani; T Takahashi; Y Suzuki; O Hasegawa
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-10       Impact factor: 10.154

2.  Clinical features, pathophysiology and treatment of dementia associated with Parkinson's disease.

Authors:  Murat Emre
Journal:  Handb Clin Neurol       Date:  2007

3.  On how P300 amplitude varies with the utility of the eliciting stimuli.

Authors:  R Johnson; E Donchin
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1978-04

4.  Visuospatial judgment. A clinical test.

Authors:  A L Benton; N R Varney; K D Hamsher
Journal:  Arch Neurol       Date:  1978-06

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

6.  Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness.

Authors:  Joana Braga Pereira; Naroa Ibarretxe-Bilbao; Maria-Jose Marti; Yaroslau Compta; Carme Junqué; Nuria Bargallo; Eduardo Tolosa
Journal:  Hum Brain Mapp       Date:  2011-09-06       Impact factor: 5.038

7.  Comparison of neurologic changes in 'successfully aging' persons vs the total aging population.

Authors:  G Odenheimer; H H Funkenstein; L Beckett; M Chown; D Pilgrim; D Evans; M Albert
Journal:  Arch Neurol       Date:  1994-06

8.  Early sensory information processes are enhanced on visual oddball and S1-S2 tasks in Parkinson's disease: a visual event-related potentials study.

Authors:  Mei Li; Yoshiyuki Kuroiwa; Lihong Wang; Toshiaki Kamitani; Tatsuya Takahashi; Yume Suzuki; Shu Omoto
Journal:  Parkinsonism Relat Disord       Date:  2003-08       Impact factor: 4.891

9.  Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.

Authors:  Emma J Burton; Ian G McKeith; David J Burn; E David Williams; John T O'Brien
Journal:  Brain       Date:  2004-01-28       Impact factor: 13.501

10.  Topographical distribution of cerebral cortical thinning in patients with mild Parkinson's disease without dementia.

Authors:  Chul Hyoung Lyoo; Young Hoon Ryu; Myung Sik Lee
Journal:  Mov Disord       Date:  2010-03-15       Impact factor: 10.338

View more
  4 in total

Review 1.  N200 and P300 component changes in Parkinson's disease: a meta-analysis.

Authors:  Hui Xu; Lihua Gu; Shiyao Zhang; Yuchen Wu; Xiaojin Wei; Caiyan Wang; Yuhan Xu; Yijing Guo
Journal:  Neurol Sci       Date:  2022-08-18       Impact factor: 3.830

2.  Action Observation in People with Parkinson's Disease. A Motor⁻Cognitive Combined Approach for Motor Rehabilitation. A Preliminary Report.

Authors:  Walter Di Iorio; Alessandro Ciarimboli; Giorgio Ferriero; Michele Feleppa; Luigi Baratto; Giuseppe Matarazzo; Giovanni Gentile; Stefano Masiero; Patrizio Sale
Journal:  Diseases       Date:  2018-07-04

3.  Impaired Phasic Discharge of Locus Coeruleus Neurons Based on Persistent High Tonic Discharge-A New Hypothesis With Potential Implications for Neurodegenerative Diseases.

Authors:  Kathrin Janitzky
Journal:  Front Neurol       Date:  2020-05-12       Impact factor: 4.003

4.  Cortical oscillatory dysfunction in Parkinson disease during movement activation and inhibition.

Authors:  Elizabeth A Disbrow; Nathaniel D Glassy; Elizabeth M Dressler; Kimberley Russo; Elizabeth A Franz; Robert S Turner; Maria I Ventura; Leighton Hinkley; Richard Zweig; Srikantan S Nagarajan; Christina R Ledbetter; Karen A Sigvardt
Journal:  PLoS One       Date:  2022-03-04       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.